FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2008249534> ?p ?o ?g. }

• W2008249534 endingPage "137" @default.
• W2008249534 startingPage "130" @default.
• W2008249534 abstract "Human apurinic endonuclease/redox factor 1 (APE/Ref-1) mediates repair of radiation-induced DNA lesions and regulates transcription via redox-based activation. We investigated the predictive and prognostic significance of APE/Ref-1 expression in pretreatment biopsy specimens in locally advanced rectal cancer (LARC) (cT3-T4 or N+).APE/Ref-1 expression was analyzed by immunohistochemistry in pretreatment biopsy specimens obtained from 83 patients with LARC. Patients received preoperative radiotherapy of 50.4 Gy in 28 fractions, combined with oral capecitabine and leucovorin chemotherapy, followed by curative surgery. The prognostic significance of various clinicopathologic characteristics, including APE/Ref-1 protein expression, was evaluated.APE/Ref-1 was expressed in 97% of patient samples. Exclusive APE/Ref-1 nuclear staining was observed in 49 of 83 samples (59%), and mixed nuclear and cytoplasmic staining was observed in 31 samples (37%). APE/Ref-1 nuclear expression levels were low in 49 patients (59%) and high in 34 patients (41%). The level of APE/Ref-1 nuclear expression was not a prognostic factor for overall and disease-free survival. Cytoplasmic expression of APE/Ref-1 was a borderline-significant predictive factor for pathologic tumor response (p = 0.08) and a significant prognostic factor for disease-free survival, as shown by univariate analysis (p = 0.037). Multivariate analysis confirmed that cytoplasmic localization of APE/Ref-1 is a significant predictor of disease-free survival (hazard ratio, 0.45; p = 0.046).APE/Ref-1 was expressed in a majority of pretreatment biopsy specimens from patients with LARC. The level of APE/Ref-1 nuclear expression was not a significant predictive and prognostic factor; however, cytoplasmic localization of the protein was negatively associated with disease-free survival. These results indicate that cytoplasmic expression of APE/Ref-1 represents an adverse prognostic factor for LARC patients who receive preoperative radiochemotherapy." @default.
• W2008249534 created "2016-06-24" @default.
• W2008249534 creator A5007640483 @default.
• W2008249534 creator A5026864988 @default.
• W2008249534 creator A5027610215 @default.
• W2008249534 creator A5029855101 @default.
• W2008249534 creator A5069919736 @default.
• W2008249534 creator A5080509268 @default.
• W2008249534 creator A5084629697 @default.
• W2008249534 creator A5088235577 @default.
• W2008249534 date "2012-01-01" @default.
• W2008249534 modified "2023-09-24" @default.
• W2008249534 title "Prognostic Significance of Human Apurinic/Apyrimidinic Endonuclease (APE/Ref-1) Expression in Rectal Cancer Treated With Preoperative Radiochemotherapy" @default.
• W2008249534 cites W1932728046 @default.
• W2008249534 cites W1971040146 @default.
• W2008249534 cites W1975839032 @default.
• W2008249534 cites W1989698903 @default.
• W2008249534 cites W1990491149 @default.
• W2008249534 cites W1996941638 @default.
• W2008249534 cites W2004442904 @default.
• W2008249534 cites W2011584267 @default.
• W2008249534 cites W2038965915 @default.
• W2008249534 cites W2044012629 @default.
• W2008249534 cites W2050742455 @default.
• W2008249534 cites W2072821594 @default.
• W2008249534 cites W2075925486 @default.
• W2008249534 cites W2076889532 @default.
• W2008249534 cites W2082545094 @default.
• W2008249534 cites W2085218834 @default.
• W2008249534 cites W2088782302 @default.
• W2008249534 cites W2090587890 @default.
• W2008249534 cites W2091079315 @default.
• W2008249534 cites W2092345873 @default.
• W2008249534 cites W2095439981 @default.
• W2008249534 cites W2116310586 @default.
• W2008249534 cites W2123942238 @default.
• W2008249534 cites W2124297369 @default.
• W2008249534 cites W2125452425 @default.
• W2008249534 cites W2127136618 @default.
• W2008249534 cites W2142459424 @default.
• W2008249534 cites W2161229780 @default.
• W2008249534 cites W2165147735 @default.
• W2008249534 cites W2210160876 @default.
• W2008249534 doi "https://doi.org/10.1016/j.ijrobp.2010.09.037" @default.
• W2008249534 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21075552" @default.
• W2008249534 hasPublicationYear "2012" @default.
• W2008249534 type Work @default.
• W2008249534 sameAs 2008249534 @default.
• W2008249534 citedByCount "7" @default.
• W2008249534 countsByYear W20082495342014 @default.
• W2008249534 countsByYear W20082495342017 @default.
• W2008249534 countsByYear W20082495342018 @default.
• W2008249534 countsByYear W20082495342021 @default.
• W2008249534 countsByYear W20082495342022 @default.
• W2008249534 crossrefType "journal-article" @default.
• W2008249534 hasAuthorship W2008249534A5007640483 @default.
• W2008249534 hasAuthorship W2008249534A5026864988 @default.
• W2008249534 hasAuthorship W2008249534A5027610215 @default.
• W2008249534 hasAuthorship W2008249534A5029855101 @default.
• W2008249534 hasAuthorship W2008249534A5069919736 @default.
• W2008249534 hasAuthorship W2008249534A5080509268 @default.
• W2008249534 hasAuthorship W2008249534A5084629697 @default.
• W2008249534 hasAuthorship W2008249534A5088235577 @default.
• W2008249534 hasConcept C121608353 @default.
• W2008249534 hasConcept C126322002 @default.
• W2008249534 hasConcept C142724271 @default.
• W2008249534 hasConcept C143998085 @default.
• W2008249534 hasConcept C150777479 @default.
• W2008249534 hasConcept C204232928 @default.
• W2008249534 hasConcept C2775934546 @default.
• W2008249534 hasConcept C2776435897 @default.
• W2008249534 hasConcept C2777028655 @default.
• W2008249534 hasConcept C509974204 @default.
• W2008249534 hasConcept C526805850 @default.
• W2008249534 hasConcept C54355233 @default.
• W2008249534 hasConcept C552990157 @default.
• W2008249534 hasConcept C63363279 @default.
• W2008249534 hasConcept C71924100 @default.
• W2008249534 hasConcept C86803240 @default.
• W2008249534 hasConceptScore W2008249534C121608353 @default.
• W2008249534 hasConceptScore W2008249534C126322002 @default.
• W2008249534 hasConceptScore W2008249534C142724271 @default.
• W2008249534 hasConceptScore W2008249534C143998085 @default.
• W2008249534 hasConceptScore W2008249534C150777479 @default.
• W2008249534 hasConceptScore W2008249534C204232928 @default.
• W2008249534 hasConceptScore W2008249534C2775934546 @default.
• W2008249534 hasConceptScore W2008249534C2776435897 @default.
• W2008249534 hasConceptScore W2008249534C2777028655 @default.
• W2008249534 hasConceptScore W2008249534C509974204 @default.
• W2008249534 hasConceptScore W2008249534C526805850 @default.
• W2008249534 hasConceptScore W2008249534C54355233 @default.
• W2008249534 hasConceptScore W2008249534C552990157 @default.
• W2008249534 hasConceptScore W2008249534C63363279 @default.
• W2008249534 hasConceptScore W2008249534C71924100 @default.
• W2008249534 hasConceptScore W2008249534C86803240 @default.
• W2008249534 hasIssue "1" @default.
• W2008249534 hasLocation W20082495341 @default.
• W2008249534 hasLocation W20082495342 @default.

• next